Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cell Therapy: early-phase trial registry
3 of 4 indexed Cell Therapy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Cell Therapy: 4 US clinical trials tracked, 3 recruiting.
Cell Therapy is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Cook MyoSite, running 1 of these trials.
Enrollment posture brief
Registry condition cell-therapy
OPEN 3 | RECR 75% | LATE 0 | EARLY 4 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Cell Therapy lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cell Therapy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cell Therapy is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
University of Arizona
NCT06643221
Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell
M.D. Anderson Cancer Center
NCT06575374
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Children's Hospital of Philadelphia
NCT06839976
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
Cook MyoSite
NCT00847535
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cell Therapy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cell Therapy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cell Therapy page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Cell Therapy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cook MyoSite sponsors the most Cell Therapy trials on record, review their full trial history before evaluating a specific study. See Cook MyoSite's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cell Therapy condition card totals 4 registered trials; most-linked intervention autologous muscle cell injection; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.